Therapeutic Focus

At Vergent Bioscience, we are committed to developing innovative products to help surgeons realize the full potential of minimally invasive and robotic-assisted surgery by improving the visibility of tumors for patients undergoing surgery for cancer.

​

As we are focused on our clinical studies, we do not currently offer access to our investigational product(s) outside of these studies. If you or someone you know would like to learn more about Vergent’s clinical trials, we encourage you to view our trials at www.clinicaltrials.gov.  

​

At this time, Vergent Bioscience does not offer an Expanded Access Program (sometimes referred to as “compassionate use” or “pre-approval access”) and we are not accepting expanded access requests. As we continue to develop investigational product(s), we will review our expanded access policy and may make updates.  

​

If you have additional questions regarding this policy, please speak with your health care provider or contact us at info@vergentbio.com.